We are live on ! Find out more
PSTV

Plus Therapeutics
PSTV

Delisted

PSTV was delisted on the 31st of July, 2026.

4 hedge funds and large institutions have $18M invested in Plus Therapeutics in 2016 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

223% more capital invested

Capital invested by funds: $5.56M → $18M (+$12.4M)

0% more funds holding

Funds holding: 44 (0)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
4
Holders Change
Holders Change %
0%
% of All Funds
0.11%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
Increased
Reduced
1
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
SI
26
SII Investments
Wisconsin
$9K
BA
27
BlackRock Advisors
Delaware
$8K
BFA
28
BlackRock Fund Advisors
California
$7K
Commonwealth Equity Services
29
Commonwealth Equity Services
Massachusetts
$7K
State Street
30
State Street
Massachusetts
$7K
FIM
31
Freedom Investment Management
Connecticut
$6K
Group One Trading
32
Group One Trading
Illinois
$6K
UBS Group
33
UBS Group
Switzerland
$6K
D.E. Shaw & Co
34
D.E. Shaw & Co
New York
$5K
HSA
35
HBK Sorce Advisory
Pennsylvania
$5K
SFA
36
Sequoia Financial Advisors
Ohio
$5K
Janney Montgomery Scott
37
Janney Montgomery Scott
Pennsylvania
$4K
RJFSA
38
Raymond James Financial Services Advisors
Florida
$4K
Creative Planning
39
Creative Planning
Kansas
$3K
Mariner
40
Mariner
Kansas
$3K
ACM
41
Argentus Capital Management
Texas
$2K
Bank of America
42
Bank of America
North Carolina
$2K
KLI
43
Kelman-Lazarov Inc
Tennessee
$2K
Wells Fargo
44
Wells Fargo
California
$2K
Manulife (Manufacturers Life Insurance)
45
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$1K
Morgan Stanley
46
Morgan Stanley
New York
$1K
Geode Capital Management
47
Geode Capital Management
Massachusetts
$193
Adage Capital Partners
48
Adage Capital Partners
Massachusetts
-$23K
AP
49
Atwood & Palmer
Missouri
-$3K
Millennium Management
50
Millennium Management
New York
-$24K

PSTV Hedge Fund Activity: Q1 2016 in Review

4 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in Plus Therapeutics (PSTV) for Q1 2016, worth a combined $18M — up 223% from $5.56M a quarter earlier.

Fund positioning in PSTV was balanced in Q1 2016: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 1 trimmed.

The largest seller was Sabby Management, cutting an estimated $1.5M.

  • 4 institutional investors held Plus Therapeutics (PSTV) as of Q1 2016, unchanged from Q4 2015.
  • Funds reported $18M of Plus Therapeutics stock for Q1 2016, up 223% quarter-over-quarter.
  • 0 funds opened new Plus Therapeutics positions in Q1 2016 and 0 closed out.
  • The largest Plus Therapeutics seller in Q1 2016 was Sabby Management, an estimated $1.5M sold.

Based on aggregated 13F filings for Q1 2016.